Literature DB >> 7749144

Analysis of estrogen and progesterone receptors on preoperative fine-needle aspirates.

B Frigo1, S Pilotti, S Zurrida, L Ermellino, A Manzari, F Rilke.   

Abstract

For 56 cases of carcinoma of the breast, results of the immunocytochemical assay for estrogen and progesterone receptors performed on preoperative fine-needle aspirates were compared with those obtained on scraping material from the same tumors. The value and usefulness of this last analysis was demonstrated in a previous study. The level of agreement between the two cytological techniques was assessed by the k statistic. A high level of agreement was found, with k values of 0.909 and 0.889 for estrogen and progesterone receptors, respectively. The results reported here revealed the reliability of steroid receptor determination on fine-needle aspiration biopsies, provided that sufficient cellularity was available. This technique can replace the open biopsy procedure, in as much as it represents a rapid, almost painless, and easily repeated method for the assessment of the receptor status, and is useful for treatment decisions at any time during the course of the disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7749144     DOI: 10.1007/BF00682725

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  25 in total

1.  Demonstration of oestrogen receptor in symptomatic breast carcinoma, using fine needle aspiration cytology.

Authors:  A Cuthbert; A Herbert; R Coddington; J Theaker; I Taylor; G T Royle
Journal:  Cytopathology       Date:  1990       Impact factor: 2.073

2.  Estrogen and progesterone receptors in breast cancer. Immunohistochemical assay on scraping material.

Authors:  B Frigo; S Pilotti; D Coradini; G La Malfa; F Rilke
Journal:  Anal Quant Cytol Histol       Date:  1992-04       Impact factor: 0.302

3.  Presurgical determination of estrogen receptor status using immunocytochemically stained fine needle aspirate smears in patients with breast cancer.

Authors:  R A McClelland; U Berger; P Wilson; T J Powles; P A Trott; D Easton; J C Gazet; R C Coombes
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

4.  Immunocytochemical detection of estrogen receptors by staining with monoclonal antibodies on cytologic specimens of human breast cancer.

Authors:  E Marchetti; A Bagni; P Querzoli; E Durante; A Marzola; G Fabris; I Nenci
Journal:  Acta Cytol       Date:  1988 Nov-Dec       Impact factor: 2.319

5.  Use of monoclonal antiestrogen receptor antibody to evaluate estrogen receptor content in fine needle aspiration breast biopsies.

Authors:  J L Flowers; G V Burton; E B Cox; K S McCarty; G A Dent; K R Geisinger; K S McCarty
Journal:  Ann Surg       Date:  1986-03       Impact factor: 12.969

6.  Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.

Authors:  L Seymour; K Meyer; J Esser; A P MacPhail; A Behr; W R Bezwoda
Journal:  Am J Clin Pathol       Date:  1990-10       Impact factor: 2.493

7.  Monoclonal antibodies to rabbit progesterone receptor: crossreaction with other mammalian progesterone receptors.

Authors:  F Logeat; M T Vu Hai; A Fournier; P Legrain; G Buttin; E Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

8.  Immunologic analysis of human breast cancer progesterone receptors. 1. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies.

Authors:  P A Estes; E J Suba; J Lawler-Heavner; D Elashry-Stowers; L L Wei; D O Toft; W P Sullivan; K B Horwitz; D P Edwards
Journal:  Biochemistry       Date:  1987-09-22       Impact factor: 3.162

9.  Evaluation of estrogen receptors by immunocytochemistry on fine-needle aspiration biopsy specimens from breast tumors.

Authors:  J Weintraub; D Weintraub; M Redard; P Vassilakos
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

10.  Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates.

Authors:  R C Coombes; T J Powles; U Berger; P Wilson; R A McClelland; J C Gazet; P A Trott; H T Ford
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

View more
  5 in total

1.  Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma.

Authors:  C Lavarino; V Corletto; A Mezzelani; G Della Torre; C Bartoli; C Riva; M A Pierotti; F Rilke; S Pilotti
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

2.  Liquid based material from fine needle aspirates from breast carcinomas offers the possibility of long-time storage without significant loss of immunoreactivity of estrogen and progesterone receptors.

Authors:  Torill Sauer; Kristin Ebeltoft; Mette Kristin Pedersen; Rolf Kåresen
Journal:  Cytojournal       Date:  2010-12-31       Impact factor: 2.091

3.  c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates.

Authors:  A Mezzelani; L Alasio; C Bartoli; M G Bonora; M A Pierotti; F Rilke; S Pilotti
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

4.  Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.

Authors:  I Soubeyran; N Quénel; L Mauriac; M Durand; F Bonichon
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

5.  pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.

Authors:  I Soubeyran; N Quénel; J M Coindre; F Bonichon; M Durand; J Wafflart; L Mauriac
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.